Senseonics (NYSE:SENS) Shares Gap Up – What’s Next?

Shares of Senseonics Holdings, Inc. (NYSE:SENS) gapped up prior to trading on Monday . The stock had previously closed at $0.96, but opened at $1.04. Senseonics shares last traded at $0.92, with a volume of 3,827,315 shares.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. StockNews.com initiated coverage on Senseonics in a research report on Thursday, December 26th. They issued a “sell” rating on the stock. HC Wainwright restated a “buy” rating and set a $2.00 price target on shares of Senseonics in a report on Friday, November 15th.

Senseonics Price Performance

The firm has a market capitalization of $565.56 million, a PE ratio of -7.31 and a beta of 0.69. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The company has a fifty day moving average price of $0.80 and a two-hundred day moving average price of $0.51.

Insider Activity at Senseonics

In other news, CFO Frederick T. Sullivan acquired 124,933 shares of the stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the transaction, the chief financial officer now directly owns 2,478,844 shares in the company, valued at approximately $941,960.72. This represents a 5.31 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Timothy T. Goodnow acquired 315,000 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were purchased at an average price of $0.31 per share, with a total value of $97,650.00. Following the transaction, the chief executive officer now owns 11,310,355 shares in the company, valued at $3,506,210.05. The trade was a 2.86 % increase in their position. The disclosure for this purchase can be found here. 3.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. First Light Asset Management LLC purchased a new stake in shares of Senseonics in the fourth quarter valued at approximately $3,366,000. Jane Street Group LLC increased its holdings in shares of Senseonics by 6,694.1% in the 4th quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock valued at $3,203,000 after purchasing an additional 6,028,726 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in Senseonics during the fourth quarter worth about $720,000. Millennium Management LLC grew its position in Senseonics by 299.0% during the fourth quarter. Millennium Management LLC now owns 1,088,029 shares of the company’s stock worth $569,000 after buying an additional 815,332 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Senseonics by 9.7% during the 4th quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company’s stock valued at $3,354,000 after acquiring an additional 566,704 shares during the period. 12.36% of the stock is currently owned by institutional investors and hedge funds.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.